Mark J. Tarr - 28 Feb 2026 Form 4 Insider Report for Encompass Health Corp (EHC)

Reporting relationship: President & CEO, Director
Issuer ticker: EHC
Reported as of: 28 Feb 2026
Net transaction value: +$3,595,982
SEC form: 4
Accepted by SEC: 03 Mar 2026, 12:10:43 UTC
Prior SEC filing: 25 Feb 2026
Next SEC filing: 11 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Patrick Darby, attorney-in-fact for Mark J. Tarr

Key filing fact

Mark J. Tarr filed Form 4 for Encompass Health Corp (EHC) on 03 Mar 2026.

Key facts

This page summarizes Mark J. Tarr's Form 4 filing for Encompass Health Corp (EHC).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Mar 2026, 12:10.

Change

Previous filing in this sequence was filed on 25 Feb 2026.
Current net transaction value: +$3,595,982.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001304057 Primary reporting owner

Tarr Mark J

Relationship: President & CEO, Director
Address: 9001 LIBERTY PARKWAY, BIRMINGHAM
Signature: /s/ Patrick Darby, attorney-in-fact for Mark J. Tarr
Signature date: 03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EHC transaction

Encompass Health Common Stock

Tax liability

Transaction value: $235,934
Shares: -2,187
Change %: -0.49%
Price: $107.88
Shares after: 440,962
Date: 28 Feb 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EHC transaction Derivative

Non-qualified Stock Option (Right to Buy)

Award

Transaction value: $3,831,916
Shares: +35,461
Change %
Price: $108.06
Shares after: 35,461
Date: 02 Mar 2026
Ownership: Direct
Underlying class: Encompass Health Common Stock
Underlying amount: 35,461
Exercise price: $108.06
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

Footnote F2

The option becomes exercisable in equal annual installments over a three-year period commencing March 2, 2027.